Proteomics and drug discovery in cancer
Highlights•Proteomics is a valuable tool for biomarker and novel therapeutic target
discovery.•Omics tools are key methodologies designed to target specific biological …
discovery.•Omics tools are key methodologies designed to target specific biological …
Proteomics and drug discovery in cancer
MH Dias, ES Kitano, A Zelanis, LK Iwai - Drug Discov. Today, 2016 - pesquisa.bvsalud.org
Proteomics has emerged as an invaluable tool in the quest to unravel the biochemical
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
Proteomics and drug discovery in cancer
MH Dias, ES Kitano, A Zelanis, LK Iwai - Drug Discovery Today, 2016 - infona.pl
Proteomics has emerged as an invaluable tool in the quest to unravel the biochemical
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
[PDF][PDF] Proteomics and drug discovery in cancer
MH Dias, ES Kitano, A Zelanis, LK Iwai - Drug Discovery Today, 2016 - csmres.co.uk
Proteomics has emerged as an invaluable tool in the quest to unravel the biochemical
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
Proteomics and drug discovery in cancer
MH Dias, ES Kitano, A Zelanis, LK Iwai - DRUG DISCOVERY …, 2016 - bv.fapesp.br
Proteomics has emerged as an invaluable tool in the quest to unravel the biochemical
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
[引用][C] Proteomics and drug discovery in cancer
MH Dias, ES Kitano, A Zelanis, LK Iwai - Drug Discovery Today, 2016 - cir.nii.ac.jp
Proteomics and drug discovery in cancer
MH Dias, ES Kitano, A Zelanis… - Drug discovery …, 2016 - pubmed.ncbi.nlm.nih.gov
Proteomics has emerged as an invaluable tool in the quest to unravel the biochemical
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
Proteomics and drug discovery in cancer.
MH Dias, ES Kitano, A Zelanis, LK Iwai - Drug Discovery Today, 2015 - europepmc.org
Proteomics has emerged as an invaluable tool in the quest to unravel the biochemical
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
Proteomics and drug discovery in cancer
MH Dias, ES Kitano, A Zelanis, LK Iwai - DRUG DISCOVERY …, 2016 - bv.fapesp.br
Proteomics has emerged as an invaluable tool in the quest to unravel the biochemical
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
Proteomics and drug discovery in cancer
MH Dias, ES Kitano, A Zelanis, LK Iwai - Drug Discov. Today, 2016 - pesquisa.bvsalud.org
Proteomics has emerged as an invaluable tool in the quest to unravel the biochemical
changes that give rise to the hallmarks of cancer. In this review, we present the advances …
changes that give rise to the hallmarks of cancer. In this review, we present the advances …